Neurocrine Biosciences (NBIX) Assets Growth (1y) (2011 - 2026)
Neurocrine Biosciences (NBIX) Assets Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.04% |
| Dec 31, 2025 | 24.55% |
| Sep 30, 2025 | 20.67% |
| Jun 30, 2025 | 17.69% |
| Mar 31, 2025 | 6.20% |
| Dec 31, 2024 | 14.37% |
| Sep 30, 2024 | 24.11% |
| Jun 30, 2024 | 26.48% |
| Mar 31, 2024 | 47.15% |
| Dec 31, 2023 | 37.27% |
| Sep 30, 2023 | 32.88% |
| Jun 30, 2023 | 30.28% |
| Mar 31, 2023 | 10.04% |
| Dec 31, 2022 | 14.29% |
| Sep 30, 2022 | 6.25% |
| Jun 30, 2022 | 2.52% |
| Mar 31, 2022 | 16.14% |
| Dec 31, 2021 | 19.47% |
| Sep 30, 2021 | 34.25% |
| Jun 30, 2021 | 29.08% |